Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

LOVE Pharma unveils operation 'Clean Hands' in California; brings in C$513,450 from financing

The sexual health and wellness firm said its subsidiary Doc Hygiene Pharmaceuticals had launched the program in the US state of California, delivering sanitizer products to homeless shelters

Love Pharma (CSE:LUV) Inc has unveiled operation 'Clean Hands' - a community program aimed at putting sanitizer products in the hands of people who need them most.

The sexual health and wellness firm said its subsidiary Doc Hygiene Pharmaceuticals had launched the program in the US state of California, delivering sanitizer products to homeless shelters.

"We identified an opportunity to support the community by providing hand sanitizer and wipes to homeless organizations in California," said Zach Stadnyk, CEO of Love Pharma (CSE:LUV) in a statement.

"In many cases these are organizations that have budget limitations and the need for sanitizer products, especially personal ones that people can have on them, are not part of the service they can regularly offer."

READ: Love Pharma launches eCommerce platform for online sales

So far, the Doc Hygiene team has delivered the 'Clean Hands' care packages to around 100 homeless shelters and organizations in California and is continuing the effort, the company added.

Also in the statement, the company said it had completed a second tranche of a non-brokered private placing, bringing in gross proceeds of C$217,000. In all, the firm raised a total of C$513,450 - issuing around 36.7 million units and 108,000 broker warrants.

The proceeds will be used for working capital and to review possible acquisitions, said the company.

The company was founded in 2020 with a mission to bring to market innovative products that enhance sexual health and wellness and improve the quality of life.

The company holds exclusive licenses to produce market, package, sell, and distribute patent-protected therapeutic and pharmaceutical products throughout Europe, the UK, and North America.

Contact the writer at giles@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK